CUREXEL
(CUREXEL TECHNOLOGIES PRIVATE LIMITED)
Bengaluru
Founded in 2023
About CUREXEL
Curexel develops painless drug delivery technology and advanced medical devices that improve the injection experience. The company designs needle-based delivery systems for vaccines, diabetes care, IVF, pain management, and other clinical applications.
Key Founders and Directors of CUREXEL
Incubators & Accelerators of CUREXEL
+2 more incubatorsPublic Links of CUREXEL
Frequently Asked Questions (FAQ)
Where is CUREXEL's headquarters?
CUREXEL is based out of Bengaluru.
When was CUREXEL founded?
CUREXEL was founded in the year 2023.
What is the legal name of CUREXEL?
The legal name of CUREXEL is Curexel Technologies Private Limited.
Who are the founders of CUREXEL?
CUREXEL is founded by Kedar Ashutosh Badnikar, Nataraja Jayadevi Shreyas and Vasudha Narasimha Swamy.
Which Incubators & Accelerators supported CUREXEL?
What are the focus areas of CUREXEL?
Who are CUREXEL's competitors?
Possible competitors of CUREXEL may include Atlamedico Techsolutions, Cutting Edge Medical Devices, Ellora Systems and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8